Pharmacist

Aspen RxHealth Selected as One of Modern Healthcare's "Best Places to Work in Healthcare" for Second Consecutive Year

Retrieved on: 
Tuesday, October 4, 2022

This is Aspen RxHealth's second consecutive year receiving this honor.

Key Points: 
  • This is Aspen RxHealth's second consecutive year receiving this honor.
  • Aspen RxHealth's mission is to enable the most responsive community of pharmacists to deliver unsurpassed outcomes for patients, their families and the customers we serve.
  • At Modern Healthcare, we are honored to celebrate the "Best Places to Work" for demonstrating their commitment to their employees, and the communities they serve, with exemplary people care measures."
  • Modern Healthcare partners with the Best Companies Group on the assessment process, which includes an extensive employee survey.

Optime Care General Manager, Brandon Salke, Pharm.D. Named Specialty Pharmacist of the Year in Prestigious 2022 Next-Generation Pharmacist Awards

Retrieved on: 
Tuesday, October 4, 2022

Optime Care , a national specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is thrilled to announce that Brandon Salke, Pharm.D., general manager and pharmacist-in-charge, Optime Care has been named Specialty Pharmacist of the Year by Pharmacy Times and Parata Systems in the 2022 Next-Generation Pharmacist Awards.

Key Points: 
  • Optime Care , a national specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is thrilled to announce that Brandon Salke, Pharm.D., general manager and pharmacist-in-charge, Optime Care has been named Specialty Pharmacist of the Year by Pharmacy Times and Parata Systems in the 2022 Next-Generation Pharmacist Awards.
  • It is so gratifying to be leading the talented team at Optime Care where every individual is dedicated to specialty pharmacy and supporting our patients with rare diseases and complex, chronic conditions.
  • Optime Care is dedicated to continuously supporting patients throughout their treatment journey so they can achieve the best possible clinical outcomes, adds Salke.
  • Optime Care has dual accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with a specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers.

Priority Health and Kroger Health announce co-branded plans to meet whole-health needs

Retrieved on: 
Tuesday, October 4, 2022

Priority Health, a nationally recognized nonprofit health plan, and Kroger Health , the health care division of The Kroger Co., announced today the launch of two co-branded Medicare plans with benefits and services that address an individuals whole-health needs and well-being.

Key Points: 
  • Priority Health, a nationally recognized nonprofit health plan, and Kroger Health , the health care division of The Kroger Co., announced today the launch of two co-branded Medicare plans with benefits and services that address an individuals whole-health needs and well-being.
  • Were excited to offer these co-branded plans with Kroger to our Medicare members in Southeast Michigan, said Samia Brown, director of senior markets and product development at Priority Health.
  • Our collaboration with Priority Health allows us the ability to offer seniors in our Michigan communities access to affordable, high-quality health care services.
  • With over 30 years in business, Priority Health is the second largest health plan in Michigan, offering an extensive portfolio of health benefits options for employer groups and individuals , including Medicare and Medicaid plans.

MC-Rx to Have Abstract Published in Journal of Managed Care & Specialty Pharmacy

Retrieved on: 
Tuesday, October 4, 2022

CAGUAS, Puerto Rico, Oct. 4, 2022 /PRNewswire/ -- Members of the MC-Rx Clinical Staff were informed by the Academy of Managed Care Pharmacy (AMCP) that their Clinical Services Department abstract entitled "Improving patient safety by decreasing co-prescribing of benzodiazepines and opioids" was accepted for a poster presentation at AMCP Nexus 2022 this month. The abstract will be displayed and discussed amongst thousands of attendees from across the nation, the majority of whom are pharmacists, physicians, nurses and other practitioners who manage medication therapies for over 270 million Americans served by health plans, pharmacy benefit management firms, emerging care models and the government. Over 300 abstract submissions were received for AMCP Nexus 2022 for possible publication in the Journal of Managed Care & Specialty Pharmacy (JMCP). Each abstract was reviewed and scored via a 2-tier peer-review process: by independent reviewers and then by a JMCP editor. The department's abstract will be published in the JMCP Abstract supplement and authorship of the abstract will be included in the meeting program.

Key Points: 
  • Over 300 abstract submissions were received for AMCP Nexus 2022 for possible publication in theJournal of Managed Care & Specialty Pharmacy(JMCP).
  • Each abstract was reviewed and scored via a 2-tier peer-review process: by independent reviewers and then by a JMCP editor.
  • The department's abstract will be published in the JMCP Abstract supplement and authorship of the abstract will be included in the meeting program.
  • For more information, please contact MC-Rx Clinical Services:
    View original content to download multimedia: https://www.prnewswire.com/news-releases/mc-rx-to-have-abstract-publishe...

FDA Awards $1.3 Million Grant to Biologics & Biosimilars Collective Intelligence Consortium

Retrieved on: 
Monday, October 3, 2022

ALEXANDRIA, Va., Oct. 3, 2022 /PRNewswire/ -- The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announcedtodaythatithasreceivedamajorgrantfromtheFood& Drug Administration (FDA) in support of biosimilars research.

Key Points: 
  • ALEXANDRIA, Va., Oct. 3, 2022 /PRNewswire/ -- The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announcedtodaythatithasreceivedamajorgrantfromtheFood& Drug Administration (FDA) in support of biosimilars research.
  • The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
  • Thestudyentitled"ImprovingtheEfficiencyofRegulatoryDecisions forBiosimilarsand Interchangeable Biosimilars by Leveraging Real-World Data to Produce Real-World Evidence"reflects BBCIC's longstanding commitment to evaluating the safety and effectiveness of biologics, including biosimilars, through the generation of reliable, real- world data (RWD) and evidence (RWE).
  • "The challenges in using real-world data and the relevance of real-world evidence for regulatorydecision-makingaboutbiosimilarsis amajorobstacle intheindustry,"saidCate Lockhart, Executive Director of the BBCIC.

Banesco USA Deploys Emergency Capital Investment Program Funds to Businesses and Borrowers in Puerto Rico and South Florida

Retrieved on: 
Monday, October 3, 2022

CORAL GABLES, Fla., Oct. 3, 2022 /PRNewswire/ -- Banesco USA is now deploying its recently received $250 million investment funds from Emergency Capital Investment Program (ECIP), particularly to minority borrowers, minority-owned businesses, small businesses, and borrowers located in underserved or minority communities in South Florida and Puerto Rico.

Key Points: 
  • CORAL GABLES, Fla., Oct. 3, 2022 /PRNewswire/ -- Banesco USA is now deploying its recently received $250 million investment funds from Emergency Capital Investment Program (ECIP), particularly to minority borrowers, minority-owned businesses, small businesses, and borrowers located in underserved or minority communities in South Florida and Puerto Rico.
  • Banesco USA closed on the greatest amount of funds for the state, as identified in the Florida Fact Sheet .
  • Examples of recent Banesco USA transactions include:
    Closed a $30 million loan to finance the construction of a new veterans recovery center in San Juan, Puerto Rico.
  • If you would like additional information about Banesco USA or its participation in the ECIP program, please visit www.BanescoUSA.com or www.BanescoUSA.com/ECIP .

Walgreens to Donate $1 Million to Aid Communities Impacted by Hurricanes Ian and Fiona

Retrieved on: 
Monday, October 3, 2022

Walgreens is supporting storm relief efforts in communities across Florida, Puerto Rico and other areas impacted by Hurricanes Ian and Fiona, with $1 million in donations announced today.

Key Points: 
  • Walgreens is supporting storm relief efforts in communities across Florida, Puerto Rico and other areas impacted by Hurricanes Ian and Fiona, with $1 million in donations announced today.
  • The American Red Cross donation goes to help all impacted communities in the aftermath of hurricanes, and will include aid to impacted regions across Puerto Rico following Hurricane Fiona, which made landfall two weeks ago.
  • Walgreens is also continuing to work with both organizations as well as community partners to donate products and essentials such as bottled water, consumables and health and hygiene items.
  • In the coming days, Walgreens customers will be able to make donations at checkout at any Walgreens store nationwide.

SingleCare Announces Fourth Annual “Best of the Best Pharmacy Awards” Recognizing America’s Top 25 Pharmacists, Techs, and Teams

Retrieved on: 
Monday, October 3, 2022

SingleCare , the free prescription savings service that delivers consistently low prices on the medications people need most, today announced the winners of its fourth annual Best of the Best Pharmacy Awards .

Key Points: 
  • SingleCare , the free prescription savings service that delivers consistently low prices on the medications people need most, today announced the winners of its fourth annual Best of the Best Pharmacy Awards .
  • The industrys preeminent program highlighting the exceptional work of pharmacy staff nationwide, the Best of the Best Awards recognizes the top pharmacists, pharmacy technicians, interns, and pharmacy teams across the country who go above and beyond in helping their communities stay healthy.
  • In total, 25 winners were named, including 10 pharmacists, nine pharmacy technicians, one pharmacy intern, and five pharmacy teams.
  • These awards highlight the selfless and tireless work that pharmacy staff do on a daily basis to keep people in their communities healthy.

Soleo Health Adds AMVUTTRA™ (vutrisiran) to Its Specialty Pharmacy Portfolio

Retrieved on: 
Monday, October 3, 2022

Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it has added AMVUTTRA (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis.

Key Points: 
  • Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it has added AMVUTTRA (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis.
  • Soleo Health employs specially trained interdisciplinary teams comprised of highly experienced pharmacists, registered nurses, reimbursement specialists and patient care ambassadors each of whom is trained on the clinical profile and administration for AMVUTTRA.
  • This marks the fourth therapy Soleo Health now offers from Alnylam Pharmaceuticals rare disease product portfolio further strengthening our ability to care for more patients living with rare disease who benefit from innovative new therapies like AMVUTTRA, said Drew Walk, Soleo Health chief executive officer.
  • Frisco, Texas-based Soleo Health is an innovative national provider of complex specialty pharmacy services administered in the home or at alternate sites of care.

Cardiol Therapeutics Announces Pre-Clinical Study Results Demonstrating CardiolRx(TM) Inhibits and also Promotes Reversal of Mechanisms Leading to Cardiac Fibrosis

Retrieved on: 
Monday, October 3, 2022

Data Presented at The Annual Scientific Meeting of the Heart Failure Society of America September 30th, 2022

Key Points: 
  • The authors concluded that the API in CardiolRx protects cardiac function and exhibits an anti-fibrotic effect, possibly mediated by endothelial-to-mesenchymal transition ("EndoMT").
  • "Our research collaborators from Houston Methodist DeBakey Heart & Vascular Center have previously shown that CardiolRx preserves cardiac function in a pre-clinical model of heart failure.
  • The results of the present study provide further evidence of the cardioprotective properties of CardiolRx that suggest anti-fibrotic mechanisms with therapeutic potential in heart failure," stated Dr. Andrew Hamer, Cardiol Therapeutics' Chief Medical Officer and Head of Research & Development.
  • These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information.